Oral sirolimus for verrucous venous malformation: a cohort study

Name: Oral sirolimus for verrucous venous malformation: a cohort study
Creator: jialu yu
Published: 2026-08-18T11:44:03.219Z
Keywords: Dermatology, Vascular Malformation, Ponatinib, Sirolimus

yu, jialu; Zhang, Gaolei; Chen, Hongguang; Wang, Xiuwei; Su, Mengting; Li, Qian; Wang, Yuhan; Zhang, Sheng; Liu, Xiaoyan; Wang, Jianhua

doi:10.17632/btdxd73nxj.7

Oral sirolimus for verrucous venous malformation: a cohort study

Published: 18 August 2026| Version 7 | DOI: 10.17632/btdxd73nxj.7

Contributors:

jialu yu, Gaolei Zhang, Hongguang Chen, Xiuwei Wang, Mengting Su, Qian Li, Yuhan Wang, Sheng Zhang, Xiaoyan Liu, Jianhua Wang

Description

"Long-term sirolimus in verrucous venous malformation cohort study and ponatinib as a potential therapeutic strategy for MAP3K3-mutatant-patient in vitro" Supplemental Data for JAAD Brief Report.

Oral sirolimus for verrucous venous malformation: a cohort study

Description

Files

Categories

Licence